Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT01223027 · COMPLETED

Trial details

NCT number: NCT01223027
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2011-03-01
Primary completion: 2014-06-01
Enrollment: 564

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.